Development of Asthmatic Response upon Bronchial Allergen Challenge Is Associated with Dynamic Changes of Interleukin-10-Producing and Interleukin-10-Responding CD4+ T Cells by Marcin Moniuszko et al.
Development of Asthmatic Response upon Bronchial Allergen
Challenge Is Associated with Dynamic Changes of Interleukin-
10-Producing and Interleukin-10-Responding CD4+ T Cells
Marcin Moniuszko,1,2,5 Kamil Grubczak,2,3 Krzysztof Kowal,1 Andrzej Eljaszewicz,2
Malgorzata Rusak,4 Marta Jeznach,1 Ewa Jablonska,3 Milena Dabrowska,4 and
Anna Bodzenta-Lukaszyk1
Abstract—The role of adaptive immune system in regulation of asthmatic responses remains elusive.
Here, we performed a comprehensive time-course analysis ofmutual relationships between development
of asthmatic response following allergen challenge and changes in several CD4+ Tcell subsets which we
characterized as either releasing interleukin-10 (CD4+CD25−CD127− and CD4+CD25+CD127+ T
cells) or responding to IL-10 (CD4+ Tcell subsets expressing CD210). Patients that developed asthmatic
reaction were described as responders (R) whereas the others were named non-responders (NR). In R, in
contrast to NR, at 6 h, we demonstrated significant expansion of CD4+CD25−CD127− T cells which
was followed by drop to baseline values at 24 h. In contrast, in R, we observed decrease in numbers of
CD4+CD25+CD127+ and CD4+CD25−CD127+ T cells at 24 h. Interestingly, at baseline, despite
comparable IL-10 levels, R presented with lower levels of all CD4+ T cell subsets expressing CD210.
In R, the numbers of CD4+CD210+ Tcell subsets were further decreased following bronchial challenge
which was paralleled by decrease in IL-10 serum levels. Altogether, our data suggest that dynamic
interactions between IL-10-producing and IL-10-responding CD4+ T cells could contribute to patho-
genesis of asthmatic responses in atopic individuals.
KEY WORDS: asthma; allergen challenge; regulatory T cells; interleukin-10; interlukin-10 receptor; interleukin-7
receptor.
INTRODUCTION
CD4+ T cells play crucial roles in regulation of im-
mune responses underlying allergic inflammation [1]. In
our previous study, we highlighted importance of natural
regulatory CD4+ T cells (Treg) in modulation of asthmatic
response in allergic individuals subject to intrabronchial
allergen challenge [2]. We demonstrated that lack of
bronchoconstriction following specific allergen bronchial
provocation is associated with transient decrease in the
number of circulating putative natural regulatory CD4+ T
cell phenotype, namely, CD4+CD25+CD127− .
Interestingly, we did not demonstrate any changes in the
number of CD4+CD25+CD127− T cells in patients who
developed classical asthmatic reaction in response to bron-
chial allergen challenge. This might suggest that other
immune mechanisms that are not related to natural Treg
cells could account for increased susceptibility to the de-
velopment of bronchoconstriction in atopic individuals.
Indeed, correlations between allergic inflammation under-
lying asthmatic responses and alterations of adaptive im-
mune system have not been investigated in sufficient de-
tail. Development of asthmatic response upon bronchial
Marcin Moniuszko, Kamil Grubczak, and Krzysztof Kowal contributed
equally to this work.
1 Department of Allergology and Internal Medicine,Medical University of
Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland
2 Department of Regenerative Medicine and Immune Regulation, Medical
University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland
3 Department of Immunology, Medical University of Bialystok,
15-274 Bialystok, Poland
4 Department of Hematological Diagnostics, Medical University of
Bialystok, 15-274 Bialystok, Poland
5 To whom correspondence should be addressed at Department of
Allergology and Internal Medicine, Medical University of Bialystok,
Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland. E-mail:
Marcin.Moniuszko@umb.edu.pl
0360-3997/14/0600-1945/0 # 2014 The Author(s). This article is published with open access at Springerlink.com
Inflammation, Vol. 37, No. 6, December 2014 (# 2014)
DOI: 10.1007/s10753-014-9927-9
1945
allergen challenge was related previously to decrease in
the number of circulating IL-4- and interferon (IFN)-gam-
ma-producing CD4+ T cells [3]. On the other hand, en-
hancement of IL-10 production by peripheral CD4+ T
cells in patients developing asthmatic response upon bron-
chial allergen challenge was demonstrated by Matsumoto
et al. [4]. To date, it remains unknown whether differential
clinical responses to allergen challenge could be also
related to dynamic quantitative changes of other CD4+ T
cell subsets, including adaptive Treg cells or non-regula-
tory CD4+ T cells. In fact, reports comprehensively de-
scribing simultaneous alterations of different T cell subsets
and data on mutual correlations among them in response
to allergen challenge are scarce. One of the major obsta-
cles for precise ex vivo delineation and/or isolation of
adaptive Treg cells is the need for in vitro stimulation of
T cells and subsequent intracellular analysis of secreted
cytokines, e.g., IL-10. Recently, however, the use of com-
bination of anti-CD25 and anti-CD127 antibodies has
allowed for precise delineation of not only natural Treg
cells (characterized by CD4+CD25+CD127− phenotype
with high expression of FoxP3), but also putative adaptive
Treg cells, namely CD4+CD25−CD127− T cells. This
subset was demonstrated to possess suppressive features
despite the absence of CD25 expression and low expres-
sion of FoxP3 [5–7]. Further studies confirmed that
CD4+T cells lacking both CD25 and CD127 did not
produce Th1-, Th2-, and Th17-associated cytokines but
secreted high amounts of IL-10 [8]. On the other hand,
dynamic changes in distribution of CD4+ Tcells with non-
regulatory phenotype (mostly positive for CD127) were
not analyzed in the context of development of asthmatic
responses in sensitive subjects exposed to specific
allergen.
Given the crucial role of IL-10-mediated actions in
regulation of allergic inflammation, we performed here a
comprehensive simultaneous analysis of those circulating
CD4+ T cells that are capable of either secreting IL-10 or
responding to IL-10 [9, 10]. We first set out to investigate
which CD4+ T cell subsets previously described as puta-
tive adaptive Treg cells negative for CD127 (CD4+CD25
−CD127− T cells) or non-regulatory CD4+ Tcells positive
for CD127 (CD4+CD25+CD127+ and CD4+CD25
−CD127+ T cells) bear the highest potential for production
of immunosuppressive IL-10 [11]. For comparison, we
assessed which CD4+ T cell subsets are most capable of
releasing Th1-characteristic cytokine exerting opposite to
IL-10 effects, namely, IFN-gamma. We aimed to analyze
whether bronchial exposure to allergen is associated with
alterations of these CD4+ T cells with varying capacities
to secrete IL-10 and IFN-gamma. We correlated these data
with time-course changes in IL-10 serum levels and abso-
lute numbers of CD4+ T cells subsets capable of
responding to IL-10-mediated signals, namely, CD4+ T
cells bearing CD210 (IL-10R). Finally, we wished to
investigate whether changes in intensity of allergen-in-
duced airway inflammation assessed by exhaled nitric
oxide measurement could be related to alterations of vary-
ing regulatory and non-regulatory CD4+ T cells.
Altogether, we presented here a novel pattern of dynamic
interactions between CD4+ T cell subsets capable of pro-




We recruited 27 individuals with a history of dyspnea
and cough following exposure to house dust and with skin
prick test reactivity to Dermatophagoides pteronyssinus
(Dp) and Dermatophagoides farinae (Df). The patients
recruited for the study were non-smokers, had no history
of other medical conditions, and had not been receiving
any treatment for asthma before the study.
Intrabronchial Allergen Challenge
All subjects were challenged intrabronchially with
Dp extract according to a protocol described elsewhere
[2]. Patients who developed asthmatic response (which
was defined as at least 20 % fall of forced expiratory
volume in 1 s) after bronchial challenge with Dp were
defined as responders (R) in contrast to non-responders
(NR). There were 18 R and 9 NR. EDTA anti-coagulated
blood was drawn before and 6 and 24 h after allergen
challenge. The study protocol was approved by local
ethics committee.
Exhaled Nitric Oxide Measurements
Assessment of nitric oxide (NO) concentration in the
exhaled air was performed using chemiluminescence ana-
lyzer NOA™ 280i (Sievers, USA), according to the
American Thoracic Society recommendations as described
previously [12]. Exhalation time and flow were 30 s and
50 ml/s, respectively, for the air exhaled by patients from
the total lung capacity. The pressure and exhalation flow
was maintained in proper range by continuous monitoring
of these parameters during the test.
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Cell Culture
EDTA anti-coagulated whole blood samples obtained
from additionally recruited eight healthy volunteers were
used to isolate peripheral blood mononuclear cells
(PBMCs) by density gradient sedimentation. PBMCs were
cultured in presence of 2 μl of phorbol 12-myristate 13-
acetate (PMA)/ionomycine/brefeldin A (Leukocyte
Activation Cocktail, BD Bioscience). PBMC cultured in
medium alone (RPMI-1640 supplemented with 10 % fetal
bovine serum and 1 % penicillin/streptomycin) served as a
negative control. Following incubation for 6 and 24 h at
37 °C in a humidified 5 % CO2 atmosphere, the cells were
harvested and washed immediately in phosphate-buffered
saline (Biomed Lublin) to prepare the cells for extracellu-
lar and intracellular staining described below. Cell death
ratio following 24-h culture assessed with the use of
trypan blue was 2.5 % for unstimulated samples and 9 %
for samples stimulated with Leukocyte Activation
Cocktail.
Immunostaining and Flow Cytometric Analysis
EDTA anti-coagulated whole blood samples or
PBMCs collected after cell culture were stained with 5 μl
of the following monoclonal antibodies: anti-CD4 FITC
(BD Biosciences), anti-CD127 PE (Beckman Coulter),
CD210 PE (BD Biosciences), anti-CD25 PE-Cy5 (BD
Biosciences), and incubated for 30 min at room tempera-
ture, in the dark. For additional intracellular staining, the
cells were permeabilized and incubated with monoclonal
antibodies directed at either IL-10 (BD Biosciences) or
IFN-gamma (BD Biosciences). Flow cytometric data were
acquired on FACSCalibur flow cytometer (BD
Biosciences, San Jose, CA, USA) and analyzed with the
use of CellQuest software and FlowJo software as de-
scribed previously [13]. Ex vivo data are presented as
absolute numbers of CD4+CD25−CD127−, CD4+CD25−
127+, and CD4+CD25+CD127+ (Fig. 1a–c) and
CD4+CD25negCD210+, CD4+CD25intCD210+, and
CD4+CD25highCD210+ T cells (Fig. 1d) per microliter of
whole blood. Data acquired from in vitro culture are pre-
sented as a proportion of CD4+CD25−CD127− or
CD4+CD25−CD127+ or CD4+CD25+CD127+ T cells re-
leasing IL-10 or IFN-gamma after stimulation with PMA/
ionomycine.
Enzyme-Linked Immunosorbent Assay
Evaluation of IL-10 concentrations in sera of pa-
tients subject to bronchial allergen challenge was
conducted using commercially available ELISA kit
(Diaclone, France). BIO-RAD microplate reader (Model
550) was used to read the ELISA plates at 450-nm
wavelength.
Statistical Analysis
Following assessment of the data, non-parametric
Wilcoxon test was used to evaluate statistical significance
of the obtained results. The Spearman’s rank correlation
coefficient was used to examine correlations. Statistically
significant results were identified by a p value of <0.05 for
all assays performed.
RESULTS
Phenotypical Characterization and Identification
of IL-10-Producing CD4+ T Cell Subsets
with Varying Levels of CD25 and CD127 Expression
Assessment of CD25 and CD127 expression serves
as a sensitive marker for delineation of natural regulato-
ry T cells characterized by CD4+CD25+CD127− pheno-
type. In contrast, much less is known about the other
CD4+ T cell subsets characterized by varying levels of
CD25 and CD127 expression. In this paper, we started
with analyzing the functional potential (with regard to
IL-10 and IFN-gamma secretion) of other than nTreg
cell subsets, namely, CD4+CD25+CD127+, CD4+CD25
−CD127+, and CD4+CD25−CD127− T cells (Fig. 2).
We demonstrated that, following 24-h PMA/ionomycine
stimulation, IL-10 is secreted by CD4+CD25−CD127−
and CD4+CD25+CD127+, but not CD4+CD25−CD127+
T cells (Fig. 2b). Interestingly, at 6 h of stimulation, only
CD4+CD25−CD127− T cells were the only subset
producing IL-10 (Fig. 2a). These results are in part in
concert with previous reports showing that CD4+ T
cells lacking CD25 and CD127 are major producers
of IL-10 [8]. In some contrast, CD4+CD25−CD127− T
cells, but not CD4+CD25+CD127+, were producing
highest levels of IFN-gamma (both at 6 and 24 h,
Fig. 2c–d). Similarly, CD4+CD25−CD127+ T cells
(that were negative for IL-10) were found positive
for IFN-gamma. Thus, CD4+CD25−CD127−T cells
turned out to produce both IL-10 and IFN-gamma,
whereas CD4+CD25+CD127+ and CD4+CD25−CD127+
T cel l s appeared to produce e i ther IL-10 or
IFN-gamma, respectively.
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Dynamic Changes of CD4+ T Cell Subsets
with Varying Levels of CD25 and CD127 Expression
Following Bronchial Allergen Challenge
Having found differential functional capacities of
CD4+CD25−CD127−, CD4+CD25+CD127+, and
CD4+CD25−CD127+ T cells, we next wished to investi-
gate whether development of asthmatic response following
bronchial allergen challenge could be associated with
changes in absolute numbers of circulating diverse CD4+
T cell subsets. First, we observed that baseline numbers of
these CD4+ T cell subsets were similar in R and NR (p=
0.279 for CD4+CD25−CD127− T cells, p=0.526 for
CD4+CD25+CD127+ T cells, and p= 0.192 for
CD4+CD25−CD127+ T cells). Further, we demonstrated
that each of the above-mentioned CD4+ T cell subsets
presented with differential pattern of redistribution after
bronchial allergen challenge. We demonstrated substantial
increase in the number of CD4+CD25−CD127− T cells in
R, but not NR (Fig. 3a). In R, at 6-h frequencies of
CD4+CD25−CD127− increased significantly from 92.38
cells/mm3 [25th; 75th percentile, 44.49; 116.7] to 110.2
cells/mm3 [73.08; 161.2] (p=0.029). At 24 h, the number
of CD4+CD25−CD127− Tcells in R dropped significantly
and returned to values similar to those observed at baseline
(from 118.6 cells/mm3 [86.38; 165.5] to 86.48 cells/mm3
[62.77; 125.9], p=0.026). In contrary, no significant
changes in the number of CD4+CD25−CD127− T cells
were observed in NR (data not shown). Opposite pattern of
changes was demonstrated for CD4+CD25+CD127+ and
CD4+CD25−CD127+ T cells of which numbers dropped
significantly after 24 h (but not 6 h) following development
of asthmatic response (from 100.8 cells/mm3 [37.00;
182.3] to 76.40 cells/mm3 [36.77; 137.3], p=0.021 and
from 349.5 cells/mm3 [274.3; 669.9] to 328.5 cells/mm3
[240.2; 490.0], p=0.021, respectively) (Fig. 3b, c). Again,
n o s i g n i f i c a n t c h a n g e s w e r e f o u n d f o r
CD4+CD25+CD127+ and CD4+CD25−CD127+ T cells







































Fig. 1. Flow cytometric plots characteristic for studied individuals. Representative FACS plots demonstrating gating strategy for identification of lymphocytes
(a), CD4+ Tcells (b), and their subpopulations, namely, CD4+CD25−CD127+, CD4+CD25+CD127+, and CD4+CD25−CD127− (c) and CD4+CD25−, CD4+
CD25dim, CD4+CD25high Tcells, and their CD210 expression (d). Precise delineation of all studied CD4+ Tcell subsets was based on fluorescence-minus-one
controls (e.g., staining only with anti-CD4 and anti-CD25, but not anti-CD127 monoclonal antibodies, or staining only with anti-CD4 and CD127, but not anti-
CD25 monoclonal antibodies).
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Dynamic Changes in IL-10 Serum Levels
Following Development of Asthmatic Response
During Bronchial Allergen Challenge
Having found changes in numbers of CD4+ T cells
capable of secreting IL-10, we next wished to investigate
changes in circulating IL-10 levels in the course of bron-
chial allergen challenge. At baseline, we did not find
significant differences in IL-10 serum levels between R
and NR (1,760 pg/ml [1,403; 2,098] and 1,990 pg/ml
[1,615; 2,520], p=0.150, respectively). However, at 24 h
following bronchial allergen challenge, we found signifi-
cant decrease in IL-10 serum levels in these individuals
who developed asthmatic response (R) (from 1,760 pg/ml
[1,378; 2,125] to 1,580 pg/ml [1,340; 1,815], p=0.049)
(Fig. 3d). Again, no difference in IL-10 levels was found in
NR (Fig. 3e).
Fig. 2. Assessment of capacity to produce IL-10 and IFN-γ by different CD4+ T cell subsets with varying levels of CD25 and CD127 expression. The
summary of analyses of IL-10 (a, b) and IFN-γ (c, d) production by diverse CD4+ T cell subsets upon 6 (a, c) and 24 h (b, d) of PMA/ionomycine stim-
ulation. The results are presented as a fraction (percentage) of cytokine-producing cells within entire CD4+ Tcell population. In the in vitro experiments, the
mean number of events acquired in CD4+CD25−CD127−, CD4+CD25−CD127+, and CD4+CD25+CD127+ gates was 9,989, 8,506, and 1,794,
respectively.
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Decreased Levels of CD4+ T Cells Expressing
IL-10R in R
Next we set out to analyze whether changes in circu-
lating IL-10 levels could be associated with alterations of
CD4+ Tcells capable of responding to actions mediated by
this cytokine, namely, cells expressing IL-10R (CD210).
Interestingly, at baseline, at 6 and 24 h, absolute numbers
of CD4+CD210+ Tcells were significantly lower in R than
in NR (time 0, 106.4 cells/mm3 [65.65–152.2] vs 309.6
cells/mm3 [154.4–333.4], p=0.005; 6 h, 68.29 cells/mm3
[57.45; 119.6] vs 166.6 cells/mm3 [135.6; 381.6], p=
0.021; 24 h, 81.18 cells/mm3 [53.04; 111.8] vs 197.2
cells/mm3 [178.3; 285.6], p=0.009). This pattern was
observed for all CD4+ T cell subsets expressing varying
levels of CD25, namely, CD4+CD25−, CD4+CD25dim,
and CD4+CD25high Tcells (Fig. 4a–c). Furthermore, in R,
but not NR, numbers of all CD4+ T cells positive for
CD210 decreased over time and were significantly lower
at 24 h as compared to those of baseline values (from 102
cells/mm3 [68.19; 146.3] to 81.18 cells/mm3 [53.04;
111.8], p=0.018).
IL-10 Levels Are Positively Correlated To Numbers
of IL-10R-Positive CD4+ T Cells but Negatively
to the Intensity of IL-10R Expression
We further investigated whether serum IL-10 levels
are correlated to levels of CD4+ T cells expressing recep-
tor for IL-10 (CD210). Notably, absolute numbers of
CD4+CD25dimCD210+ and CD4+CD25highCD210+ T
cells in R were positively correlated to serum IL-10 levels
at each time point, with the exception of 24 h (Table 1).
We then set out to analyze whether similar pattern can be
observed for mean fluorescence intensity of CD210.
However, in contrast to analysis of absolute numbers of
CD210+ cells, mean fluorescence intensity of this receptor
on CD4+CD25dim and CD4+CD25high was negatively
correlated to serum IL-10 levels at 24 h (Table 2). In NR,
baseline levels of serum IL-10 were positively correlated
to absolute numbers of CD4+CD25highCD210+ T cells
(Table 1), while no correlation between IL-10 levels and
mean fluorescence intensity of CD210 in studied T cell
subpopulations was found (Table 2).
Positive Correlations Among Putative IL-10-Secreting
and IL-10-Responding CD4+ T Cell Subsets
We next searched the pattern of mutual relationships
between putative IL-10-producing CD4+ T cells and those
CD4+ Tcell subsets that express surface receptor for IL-10.
We d emo n s t r a t e d t h a t , i n R , n umb e r s o f
CD4+CD25dimCD210+ were positively correlated with
CD4+CD25+CD127+ (Fig. 5a), but not CD4+CD25−
CD127− T cells (Fig. 5b) at each time point. Moreover,
absolute numbers of CD4+CD25highCD210+ were posi-
tively correlated with CD4+CD25+CD127+ (Fig. 5c) and
CD4+CD25−CD127− (Fig. 5d) T cells (at each time
point). On the other hand, we did dot observe any signif-
icant correlation in NR.
Lack of Correlations Among Exhaled Nitric
Oxide Levels and Levels of IL-10-Producing
and IL-10-Responding CD4+ T Cell Subsets
We finally wished to investigate whether numbers of
circulating both IL-10-producing and IL-10-responding
CD4+ T cell subsets can be correlated to intensity of
allergic airway inflammation routinely measured by as-
sessment of nitric oxide concentrations in exhaled air.
However, none of the studied CD4+ T cell subsets was
found directly related to the levels of exhaled nitric oxide in
atopic subjects (Table 3).
DISCUSSION
Here, we described a novel pattern of dynamic chang-
es of circulating CD4+ T cells with both regulatory and
non-regulatory phenotypes in the context of development
of asthmatic response following bronchial allergen chal-
lenge. First, we extended our knowledge on functional
characteristics of CD4+ T cells with varying levels of
expression of two crucial for CD4+ T cell homeostasis
cytokine receptors, namely, CD127 and CD25. To date,
according to scarce reports, CD4+ T cells positive for
CD127 were considered non-regulatory in contrast to reg-
ulatory CD127-negative CD4+ T cells: natural
CD4+CD25+CD127− and adaptive CD4+CD25−CD127−
T cells [5]. Here, we further characterized the functional
capacities of CD127-negative and CD127-positive CD4+
Tcell subsets and confirmed in part findings of Liu et al. and
Couper et al.whowere referring to CD4+CD25−CD127−T
Fig. 3. Time-course changes in absolute numbers of CD4+ T cell subsets
characterized by varying levels of CD25 and CD127 expression (in R).
(a, c) The summary of analyses of changes in absolute numbers of CD4+
CD25−CD127− (a), CD4+CD25−CD127+ (b), and CD4+CD25+C-
D127+ (c) T cells at 0 versus 6 h (left column) and 6 versus 24 h (right
column) after allergen challenge. d–e The summary of analyses of changes
in IL-10 serum concentrations at 0 versus 24 h after allergen challenge in R
(d) and NR (e).
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cells as putative Tr1 cells, as these cells were shown to
secrete IL-10 [5, 8]. Interestingly, capability to release IL-
10 upon stimulation was not conferred only to CD4+
CD25−CD127− T cells, as we demonstrated that similar
feature is characteristic also for CD4+CD25+CD127+ T
cells (Fig. 2). Notably, the latter subset was capable of
selective IL-10, but not IFN-gamma production.
Nonetheless, according to many reports, any classifications
of human CD4+ Tcell subsets to any Th subclass need to be
taken with a great caution [14–17]. This notion is also
supported by our current data demonstrating that putative
Tr1 CD4+CD25−CD127− T cells secreting IL-10 are also
capable of high IFN-gamma production rather being a fea-
ture of Th1 cells [18]. Importantly, our results indicate that
neither CD25 nor CD127 expression is exclusively related
to capability to secrete IL-10. Therefore, in the current
report, we decided to precisely describe and present pheno-
type of studied CD4+ T cells rather than refer to them as to
either Tr1 or Th1 cells.
Here, we used well-s tandardized allergen
bronchoprovocation model because despite its laborious
character it provided us a unique opportunity for observing
dynamic interactions between allergen-induced
bronchoconstriction and alterations of immune system
[19–21]. Previously, using the samemodel, we demonstrat-
ed that changes in numbers of CD4+ T cells with natural
regulatory phenotype were associated with protection from
development of bronchoconstriction following bronchial
allergen challenge [2]. In contrast, here, we found that
circulating CD4+CD25−CD127− (putative IL-10- and
IFN-gamma-producing) T cells were significantly enriched
during allergen challenge in individuals with asthmatic
reaction (Fig. 3). It remains unknown whether this change
represents mobilization of potential anti-inflammatory
cells that could counterbalance the effects of asthmatic
airway inflammation. Interestingly, the nature of these
interactions seems more complex than expected as we
demonstrated here that intensity of allergic airway inflam-
mation assessed bymeasurements of exhaled nitric oxide is
not directly correlated to the numbers of circulating CD4+
T cell subsets. Regardless the mechanism, comparison of



















































































































































Fig. 4. Quantification of changes of CD4+ T cell subsets expressing CD210 in the course of intrabronchial allergen challenge. The summary of analyses of
numbers of CD4+ T cells expressing varying levels of CD25 and CD210, namely, CD4+CD25−CD210+ (a), CD4+CD25dimCD210+ (b), and CD4+C-
D25highCD210+ (c).
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those published previously on natural regulatory CD4+ T
cells suggests that both subsets may play differential roles
in orchestrating immune responses accounting for devel-
opment of airway hyperreactivity.
In addition, our data indicate that enhanced mobiliza-
tion of circulating putative IL-10-secreting and IFN-gam-
ma-secreting CD4+ T cells (putative Tr1+Th1 T cells) is
not sufficient to inhibit development of asthmatic reaction
in allergic individuals. Based on previous reports, we could
speculate that coexistence of Tr1 and Th1 lineages in single
CD4+ Tcell subset could result in functional diminishment
of either Tr1- or Th1-like functions [20]. Moreover, we
demonstrated that asthmatic reaction is accompanied by
significant drop in serum levels of IL-10 (Fig. 3d). One
could hypothesize that this drop in serum IL-10 levels was
caused by lack of mobilization (and even significant drop)
of CD4+CD25+CD127+ T cells, selectively secreting IL-
10, but not IFN-gamma. It is possible that therapeutic
s t r a t e g i e s a imed a t e n h a n c emen t o f t h e s e
CD4+CD25+CD127+ T cells being selective IL-10 pro-
ducers could be of potential benefit in immune modulation
of asthmatic response. Altogether, our data suggest
that airway allergen challenge is counteracted by mo-
bilization of certain (but not all) IL-10-dependent anti-
inflammatory mechanisms that, on the other hand, are
not sufficient to inhibit development of asthmatic
response.
Notably, we demonstrated here that decreased IL-10
concentrations following bronchial allergen challenge are
accompanied by decrease in absolute numbers of
CD4+25dim IL-10R+ and CD4+CD25high IL-10R+T
cells (Fig. 4). Interestingly, decreased number of CD4+
T cells expressing IL-10R was paralleled (before and
24 h after bronchial challenge) by enhancement of mean
fluorescence intensity of this receptor on CD4+ T cells.
This strong positive correlation suggests an existence of
Table 1. Correlations Among IL-10 Serum Levels and Absolute Numbers of CD4+CD210+ Subpopulations
R NR
Time (h) Population p value r p value r
0 CD4+CD25−CD210+ 0.115 0.707 0.782 −0.126
CD4+CD25dimCD210+ 0.025 0.539 0.556 0.288
CD4+CD25highCD210+ 0.001 0.696 0.006 0.937
6 CD4+CD25−CD210+ 0.310 0.357 0.950 0.100
CD4+CD25dimCD210+ 0.002 0.758 0.683 0.300
CD4+CD25highCD210+ 0.003 0.727 0.083 0.900
24 CD4+CD25−CD210+ 0.472 0.276 1.000 −0.028
CD4+CD25dimCD210+ 0.249 0.360 1.000 −0.028
CD4+CD25highCD210+ 0.001 0.789 0.279 0.542
Bold values denote statistically significant correlations
Table 2. Correlations Among IL-10 Serum Levels and Mean Fluorescence Intensity of CD210 on Diverse CD4+ T Cell Subsets with Varying Levels of
CD25 Expression
R NR
Time (h) Parameter p value r p value r
0 CD210 MFI of CD4+CD25− 0.916 −0.030 0.461 −0.311
CD210 MFI of CD4+CD25dim 0.644 −0.116 0.500 −0.275
CD210 MFI of CD4+CD25high 0.227 −0.299 0.461 −0.311
6 CD210 MFI of CD4+CD25− 0.711 −0.131 0.802 −0.142
CD210 MFI of CD4+CD25dim 0.982 −0.006 0.919 −0.085
CD210 MFI of CD4+CD25high 0.764 −0.088 0.802 −0.142
24 CD210 MFI of CD4+CD25− 0.712 −0.133 0.115 −0.619
CD210 MFI of CD4+CD25dim 0.022 −0.532 0.096 −0.642
CD210 MFI of CD4+CD25high 0.019 −0.613 0.115 −0.610
Bold values denote statistically significant correlations
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interesting axis between IL-10-producing and IL-10-
responding CD4+ T cells: Limited amounts of IL-10
seem to be preserved for lesser number of CD4+IL-
10R+T cells that in turn express higher levels of this
receptor. Altogether, these data support the observation
that local exposure to allergen affects trafficking of dif-
ferent T cell subsets and therefore is associated with
systemic alterations of T cell-mediated immunity. This
pattern does not seem to be restricted only to adaptive
immune system, as we recently demonstrated that airway
allergen challenge led to significant alterations of differ-
ent monocyte subsets [22].
Recent reports indicated that the use of IL-10-targeted
experimental therapies could provide protection against
asthma in mouse model of this disease [9, 23, 24]. Our
data confirm that existing IL-10-dependent mechanisms in
atopic patients prone to development of asthma are not
sufficient: These patients have lower numbers of CD4+ T
cells positive for IL-10R, and in addition, their IL-10 levels

























































































































































































































































































Fig. 5. Correlations between putative IL-10-producing CD4+ Tcells and CD4+Tcell subsets expressingCD210 (in R). The summary of correlation analyses
of absolute numbers of CD4+CD25dimCD210+ and CD4+CD25+CD127+ (a) or CD4+CD25−CD127− (b) T cells or absolute numbers of CD4+CD25-
highCD210+ and CD4+CD25+CD127+ (c) or CD4+CD25−CD127− (d) T cells at 0 h (upper line), 6 h (middle line), and 24 h (lower line).
Table 3. Correlations Between Exhaled Nitric Oxide Concentrations and Analyzed CD4+ T Cell Subsets
R NR
T cell subpopulation p value r p value r
CD4+CD25−CD127− 0.594 0.250 1.000 0.500
CD4+CD25+CD127+ 0.906 0.071 0.333 1.000
CD4+CD25−CD127+ 0.138 0.642 1.000 −0.500
CD4+CD25−CD210+ 0.782 −0.142 0.159 −0.968
CD4+CD25dimCD210+ 0.839 −0,107 0.333 1.000
CD4+CD25highCD210+ 0.661 0.214 0.333 1.000
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of these alterations provides another evidence that the need
for further development of therapeutic anti-asthmatic strat-
egies aimed at IL-10/IL-10R axis is still warranted. On the
other hand, our observation of decreased baseline IL-10R
levels in R suggests that determination of IL-10R on CD4+
T cells could become a useful predictor of occurrence of
asthmatic response in atopic subjects. Thus, assessment of
IL-10R on CD4+ T cells could help in prospectively iden-
tifying these atopic subjects who are at higher risk of
developing bronchoconstrictive reactions.
CONCLUSIONS
In summary, we presented here novel pattern of mutual
interactions between CD4+ Tcell subsets capable of produc-
ing IL-10 and those that could respond to its actions mediated
by IL-10R in the course of bronchial challenge with specific
allergen. In addition, our data suggest that strategies targeting
IL-10/IL-10R axis could be helpful in alleviating intensity of
bronchial responses following exposure to allergens.
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